Key result
Hypertensive rats exhibit impaired 11beta-HSD1 activity and expression compared with normotensive controls.
Answers are grounded in this paper and cite their sources.
Reveals impaired 11beta-HSD1 enzyme activity in Lyon hypertensive rats, suggesting that defective corticosteroid metabolism mirrors phenotypes of enzyme knockout models.
Adrenocorticosteroid activity in Lyon hypertensive (LH) and low blood pressure (LL) rat strains differ in several respects. Abnormal activity of 11beta-hydroxysteroid dehydrogenase enzymes (11beta-HSD1 and 11beta-HSD2), which interconvert corticosterone and inactive 11-dehydrocorticosterone, might contribute to the LH phenotype by regulating corticosteroid hormone access to receptors. 11beta-HSD2 (expressed in kidney but not liver) prevents endogenous glucocorticoids from binding to mineralocorticoid receptors. 11beta-HSD1 (expressed in liver and kidney) favors active glucocorticoid formation from 11-dehydrocorticosterone. 11beta-HSD properties in LH and LL have been compared by several approaches: (1) 11betaHSD activities have been measured in vitro as corticosterone dehydrogenation and in vivo as interconversion of injected cortisol and cortisone; (2) the effects of cortisol and cortisone on urine electrolytes and volume have been measured; and (3) 11beta-HSD mRNA expression has been measured by in situ hybridization. 11beta-HSD2 enzyme activities in LH and LL rats were similar and urinary cortisone:cortisol ratios were not different after cortisol injection. Cortisol caused a natriuresis and kaliuresis in both strains, with a slightly reduced response in LH rats. Renal 11beta-HSD2 mRNA expression was slightly lower in LH rats. 11beta-HSD1 was less active in LH than LL rats: enzyme activities were lower in tissue extracts; urinary cortisone:cortisol was lower in LL rats after cortisone injections; cortisone increased urine volume in LL but not LH rats; and mRNA levels tended to be lower in LH tissues. We conclude that 11beta-HSD1 is impaired in LH rats. The LH phenotype of heavier adrenals, raised corticosterone, and reduced thymus weight is similar to that described for 11beta-HSD1 knockout mice.
No takes yet. Share an insight, caveat, or question.
Lloyd-MacGilp et al. (1999) studied Hypertension (Lyon hypertensive rat model). Injected cortisol and cortisone / Lyon hypertensive (LH) strain phenotype vs. Lyon low blood pressure (LL) rat strain was evaluated on 11beta-hydroxysteroid dehydrogenase (11beta-HSD1 and 11beta-HSD2) enzyme activity, mRNA expression, and urinary electrolyte/volume responses. Lyon hypertensive rats exhibited impaired 11beta-HSD1 activity and reduced mRNA levels compared with low blood pressure rats, while 11beta-HSD2 enzyme activities were similar between strains.
Synapse has enriched 10 related papers. Consider them for comparative context: